Tumor-targeting, systemically delivered antisense HER-2 chemosensitizes human breast cancer xenografts irrespective of HER-2 levels. [electronic resource]

By: Contributor(s): Producer: 20030327Description: 475-86 p. digitalISSN:
  • 1076-1551
Subject(s): In: Molecular medicine (Cambridge, Mass.) vol. 8
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

There are no comments on this title.

to post a comment.